Topglove on the other hand has making insane profits from the pandemic, whilst having documented labour rights abuses, blatant disregard to the community's health, covering up it's wrong doings (a few to 2k to 5k covid cases ring a bell), then spending billions in share buybacks which could have. even used to improve the living conditions and livelihoods of its employees. If anything the shorts at less than 3% are the minorities. Glove lovers are so blinded by greed they don't even know what's right or wrong

You got to be joking. Gamestop is a company that had been losing money, and then was the target of wallstreet hedge fund shorts all the way to bankruptcy. It is literally the David vs Goliath. Your everyday man is taking the fight to wallstreet.

Tmr last day Jan
Then next week February CNY and vaccines coming !
Dong dong dong chiang then jab jab jab ho ho ho
Just ah !!!

Pfizer-BioNTech has increased production to 2 bil Moderna min 600mil to 1bil
Don't spread fake news.
Sobering 'fact' and what you choose to only see are two different things

UK coronavirus cases drop to a THIRD of figure three weeks ago !
Daily Mail PUBLISHED: 16:50 GMT, 26 January 2021 | UPDATED: 21:44 GMT, 26 January 2021

https://klse.i3investor.com/blogs/emsvsi/2021-01-27-story-h1540182882-BREAKING_UK_coronavirus_cases_drop_to_a_THIRD_of_figure_three_weeks_ago.jsp

UK coronavirus cases drop to a THIRD of figure three weeks ago !
Daily Mail PUBLISHED: 16:50 GMT, 26 January 2021 | UPDATED: 21:44 GMT, 26 January 2021

https://klse.i3investor.com/blogs/emsvsi/2021-01-27-story-h1540182882-BREAKING_UK_coronavirus_cases_drop_to_a_THIRD_of_figure_three_weeks_ago.jsp

UK coronavirus cases drop to a THIRD of figure three weeks ago (DON'T MISS THIS RECOVERY STOCK!)

PUBLISHED: 16:50 GMT, 26 January 2021 | UPDATED: 21:44 GMT, 26 January 2021

>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>

https://klse.i3investor.com/blogs/emsvsi/2021-01-27-story-h1540182882-BREAKING_UK_coronavirus_cases_drop_to_a_THIRD_of_figure_three_weeks_ago.jsp

BREAKING NEWS

Pfizer to Deliver U.S. Vaccine Doses Faster Than Expected: CEO
By Riley Griffin
January 26, 2021, 9:51 PM GMT+8

Pfizer Inc. will be able to supply the U.S. with 200 million Covid-19 vaccine doses two months sooner than previously expected, according to its top executive.

Chief Executive Officer Albert Bourla said Tuesday that the drugmaker and its partner, BioNTech SE, will be able to deliver more doses to the U.S. and European Union before the end of the second quarter due to a change in the vaccine’s label that allows health-care providers to extract an additional dose from each vial.

In the U.S., Pfizer and BioNTech will deliver 120 million doses in the first quarter, 20 million more than initially promised, Bourla said in an interview with Bloomberg Editor-in-Chief John Micklethwait at the Year Ahead Summit, held virtually this year.

New York-based Pfizer has supplied governments with 36 different combinations of commercially available needles and syringes to be able to extract the last dose from the vials, Bourla said.

The change in Pfizer’s timeline comes amid heightened anxiety over the sluggish pace of the vaccine rollout and concern over a limited supply of doses. Bourla said that the U.S. rollout was particularly slow in its first few weeks, though he expects the pace of administered doses to improve.

Vaccinations in the U.S. began Dec. 14 after the Pfizer-BioNTech vaccine was authorized for emergency-use. Moderna Inc.’s vaccine, which relies on a similar technology known as messenger RNA, was cleared shortly thereafter. So far 23.5 million shots have been given, according to Bloomberg’s Vaccine Tracker. In the last week, an average of 1.25 million doses per day were administered.

In all, Pfizer and BioNTech have said they plan to produce 2 billion doses in 2021, a 50% increase from estimates given last year. While the companies plan to ramp up output with the help of additional contract manufacturers, the new target also takes into account a label change that allows doctors to extract six doses instead of five from each vaccine vial.

https://www.bloomberg.com/news/articles/2021-01-26/pfizer-to-deliver-u-s-vaccine-doses-faster-than-expected-ceo


Notes: USA 1.25 mil doses per day (currently - news of plans to bump it up to 1.5 mil or higher).
Pfizer-BioNTech now 2 bil doses in 2021 50% increase from earlier estimates

Pfizer-BioNTech - Feb
Sinovac - April (based on Berita Harian link as above)
Sputnik - Mar
AstraZeneca - 2Q21
Cansino (yet to be announced)

Khairy has announced a 'ring vaccination' strategy - as I interpret it to vaccinate the areas with the most outbreaks, most populous and most cases first. You do not need 100% vaccinations for herd immunity to come into effect

Rather than look at the total number of people who've been vaccinated, you choose to focus on the 1 rare case out of millions

Misinformation will kill more people than vaccines ever will

Recovery is real and it is here. What is a few more months when you are already at the end of the tunnel and the light is shining on your face

Buy as much as possible with full conviction and hold on for the greatest super bull run in Genting's history in 2021 the year of the Ox

Dokumen perolehan vaksin buatan China, Russia ditandatangani
Oleh Rafidah Mat Ruzki - Januari 26, 2021 @ 6:17pm

Kementerian dalam satu hantaran Facebook hari ini, menyatakan Syarikat PLS akan membekalkan sebanyak 12 juta dos COVID-19 CORONAVAC, SARS-COV-2 Vaccine (Vero Cell) Inactivated yang dihasilkan oleh syarikat dari China, Sinovac Life Science Co Ltd.

Kenyataan itu menyebut, pembekalan vaksin itu dijangka dilaksanakan secara berperingkat-peringkat mulai April ini manakala, Syarikat Duopharma (M) Sdn Bhd pula akan membekalkan sebanyak 6.4 juta dos vaksin Sputnik V yang dihasilkan oleh Gamaleya Research Institute of Epidemiology and Microbiology di Russia.

"Vaksin ini dijangka mula dibekalkan secara berperingkat mulai penghujung Mac 2021.

https://www.bharian.com.my/berita/nasional/2021/01/780160/dokumen-perolehan-vaksin-buatan-china-russia-ditandatangani


In March 2021 the vaccinations for Malaysia shall begin in earnest

Inter-state travel allowed for long-distance married couples starting Jan 27, says Ismail Sabri
Tuesday, 26 Jan 2021 5:33 PM MYT

https://www.thestar.com.my/news/nation/2021/01/26/ismail-sabri-govt-to-allow-inter-state-travel-on-jan-27


Comments: I wonder if they allow gamblers to go genting if they say casino is their partner ! ha ha ha

Catalysts:
MCO eased
CNY rally
Pfizer-BioNtech vaccine arrives and vaccination starts (MY)
Other vaccines to be announced (MY)
US & UK vaccinations roll out (RW NYC, RW Catskills, RW LV, Genting UK)
News of drop in infection rates (Israel, EU, UK etc)
Celularity Inc 2Q21 listing

Cycles always repeat e.g. economic cycle and recession (10 years), stock market cycle, commodities cycle...

2009 Global Financial Crisis (GFC)
2020 Covid-19 Pandemic

2009 Year of the Ox (aka Super Bull)
2021 Year of the Ox (aka Super Bull)

2009 Mar RM3.08 (low) to 2011 Nov RM11.98 (high)
2020 Nov RM2.95 (low) to 2021 RM ????

After every recession Genting goes on a super bull run as the economy accelerates

History always repeats itself

Sincerely,
EMSVSI

Target Price (at 26 Jan 2021 @ 12.30pm)
--------------------------------

1st TP: RM 7.55 (Market Capitalisation of Listed Entity only)

Entity: Ownership (%) and Market Capitalisation and Exchange Rate = Value (RM Billion) at Share Price or Value per Genting share

GenS: 52.7% x SGD 10.436 bil x 3.05 = RM 16.775 bil (@ SGD0.865 or 86.5c) or RM4.32

GenM: 49.5% x MYR 14.311 bil = RM 6.996 bil (@ RM2.38) or RM1.80

GenP: 55.4% x MYR 8.749 bil = RM 4.802 bil (@ RM9.66) or RM1.24

Celularity: 10% x USD 1.7 bil 4.04 = RM0.687 bil (*2Q21 listing; assumes 10% only) or RM0.177

Number of Shares: 3.877 bil

Most conservative method taking into account the market capitalisation of GenS GenM GenP only, while assigning ZERO value to Energy, Life Sciences, Management Services etc

Even at the most conservative target price RM7.55, the upside potential from current share price RM3.98 is significant i.e. 89.6%

Remember, GenS makes up the bulk of GenT value and the value of GenS alone is RM4.33 per Genting share

As shared earlier

Before the travel ban was lifted on Dec 7, in the week of 30 Nov - 4 Dec , Genting share price range was between RM 4.06 - 4.25

Difference now is 1) Pfizer-BioNTech vaccine is coming Feb next month 2) Other vaccines are coming 3) Celularity Inc listing

BREAKING NEWS !

Health Ministry says govt not keen to implement MCO for a long period
By JOSEPH KAOS JR
NATION
Monday, 25 Jan 2021 5:55 PM MYT

PUTRAJAYA: The Health Ministry has hinted that the current movement control order (MCO) will end, followed by three months of conditional MCO.

Health director-general Tan Sri Dr Noor Hisham Abdullah said the government is not keen to implement the MCO for a long period due to the livelihoods it could affect.

“We do not want to prolong the MCO.

“If we implement the MCO for four weeks until early February, and then followed by a conditional MCO for three months, we hope we can reduce the number of Covid-19 cases to double figures, ” said Dr Noor Hisham, at a virtual press conference on Monday (Jan 25).

Currently, the MCO is being imposed in all states except Sarawak and will last until Feb 4.

https://www.thestar.com.my/news/nation/2021/01/25/health-ministry-says-govt-not-keen-to-implement-mco-for-a-long-period

BREAKING [Complete Economic Shutdown]: (Actual) Eurocham Letter to Members (dated 23 Jan 2021) following meeting with MITI on 22 Jan 2021

https://klse.i3investor.com/blogs/emsvsi/2021-01-24-story-h1540126365-BREAKING_Complete_Economic_Shutdown_Actual_Eurocham_Letter_to_Members_d.jsp

Notes: Manufacturing sector is the main source of infections with 99 out of more than 300 in the country


Miti appeals to manufacturing sector to help curb Covid-19 to keep economy open, Eurocham tells members

https://www.thestar.com.my/news/nation/2021/01/24/miti-appeals-to-manufacturing-sector-to-help-curb-covid-19-to-keep-economy-open-says-eurocham

BREAKING NEWS


1) More proof Britain's Covid crisis is past its peak? ONS says cases dropped last week, separate study shows new infections HALVED in a fortnight and No10's own data reveals deaths in London are falling
By SAM BLANCHARD DEPUTY HEALTH EDITOR FOR MAILONLINE
PUBLISHED: 08:49 GMT, 22 January 2021 | UPDATED: 13:58 GMT, 22 January 2021

Full article: https://www.dailymail.co.uk/news/article-9175387/Coronavirus-UK-London-deaths-appear-start-falling-app-estimates-daily-infections-plunge.html


2) UK Covid-19 data showing new cases and deaths falling: https://www.worldometers.info/coronavirus/country/uk/
Seeing is believing


3)
a)COVID-19: UK vaccine rollout speeds up but doctors want quicker second dose
24 Jan 2021 03:46AM
(Updated: 24 Jan 2021 06:18AM)


b) COVID-19: Almost 5.4 million people given first vaccine dose as UK reports another 1,401 deaths
The health secretary says the NHS is vaccinating people against coronavirus at the rate of 200 jabs every minute.
Friday 22 January 2021 21:59, UK

More than 5,000,000 people in the UK have now received at least one dose of a COVID-19 vaccine, according to latest government figures.

It means that 10.2% of people over 18 in the UK have had their first dose against coronavirus.

https://news.sky.com/story/covid-19-more-than-5-million-people-given-first-vaccine-dose-as-uk-reports-another-1-401-deaths-12194446


Genting UK !

BREAKING NEWS

CDC reports record number of daily Covid-19 vaccinations as states struggle with supply
By Theresa Waldrop, Madeline Holcombe and Jason Hanna, CNN
Updated 0757 GMT (1557 HKT) January 23, 2021

(CNN)The US Centers for Disease Control and Prevention reported its biggest one-day increase in Covid-19 vaccinations Friday as more states said they are struggling with vaccine supply.

The CDC said Friday that nearly 1.6 million more doses of the vaccines have been administered, bringing the total of doses given to more than 19 million.

-----------------

US could be almost back to normal by fall, Fauci says

Despite challenges with distributing and administering Covid-19 vaccines, the US "can and should" vaccinate 70-85% of adults by the end of summer, Fauci said.

That could bring a semblance of normalcy by the fall, according to Fauci, the director of the National Institute of Allergy and Infectious Diseases.

https://edition.cnn.com/2021/01/22/health/us-coronavirus-friday/index.html


Genting US: RW Las Vegas, RW NYC, RW Catskills !

GENS closed unchanged
GENM closed up 0.84%
GENT down this is called anomaly
Wait next month Feb CNY and vaccine coming
Hoot9e !!!

Keep telling glove lovers Genting made up of GenS which alone is worth 4.3x per Genting share, not including GenP which is an upcycle, and unlisted Energy which is cash cow and now Life Sciences which, judging from the US markets obsession with biotech and tech, would be a multi bagger ho ho ho

All are welcome to join Genting you will never be able to buy the blue chip at this price again

On 12 Jan MCO2.0 was announced on 6 states, including Selangor and KL and on 19 Jan MCO2.0 extended to all peninsula states. old news better to close and do maintenance then open and swat flies ha ha ha

BREAKING NEWS !

Pfizer vaccine appears effective against coronavirus variant found in Britain — study
Ludwig Burger / Reuters

January 20, 2021 18:50 pm +08

FRANKFURT (Jan 20): The Covid-19 vaccine developed by Pfizer and BioNTech is likely to protect against a more infectious variant of the virus, which was discovered in Britain and has spread around the world, according to results of further lab tests released on Wednesday.

The encouraging results from an analysis of blood of participants in trials are based on more extensive analysis than those released by the US drug maker last week.

Last week, Pfizer said a similar laboratory study showed the vaccine was effective against one key mutation, called N501Y, found in both of the highly transmissible new variants spreading in Britain and South Africa.

The latest study, posted on bioRxiv.org but not yet peer-reviewed, was conducted on a synthetic virus with 10 mutations that are characteristic of the variant known as B117 identified in Britain.

Among the 11 authors of the study are Ugur Sahin and Oezlem Tuereci, co-founders of BioNTech. Sahin is chief executive and his wife Tuereci is chief medical officer.

It provides further hope as record numbers of daily deaths from Covid-19 are reported in Britain, which is believed to be driven by the more transmissible variant. It also means vaccine development would for now not have to start all over again.

For the test, blood samples drawn from 16 vaccinated participants in prior clinical trials were exposed to a synthetic virus called pseudovirus, which was engineered to have the same surface proteins as B117, as characterised by 10 hallmark mutations.

The antibodies in the blood of the volunteers given the vaccine, known as Comirnaty, or BNT162b2, neutralised the pseudovirus as effectively as the older coronavirus version that the product was initially designed for.

https://www.theedgemarkets.com/article/pfizer-vaccine-appears-effective-against-coronavirus-variant-found-britain-%E2%80%94-study

Stock: [TOPGLOV]: TOP GLOVE CORP BHD

Posted by emsvsi > Jan 14, 2021 12:30 PM | Report Abuse X

The breakout above MA200 has failed

The beginning of the end

Fundamentals still prevail. Based on true normalised earnings, not one-off events

And remember, markets are always forward looking, not just on the next few quarters

Sincerely,
EMSVSI

1)
The Black Death occurred between 1347-1351 and killed approximately 75-200 million people

The Spanish Flu occurred between 1918-1920 and killed approximately 17-50 million people

- The pandemics ended quicker and with lower deaths

- Both ended naturally without vaccines


2)
The COVID-19 outbreak started in Dec 2019

To date it has infected approximately 96 million with 2.06 million deaths (mortality rate ~2%)

- On 11 Jan 20, the SARS-CoV-2 genetic sequence was published

- On 13 Jan 20, just 2 days later, Moderna finalised its COVID-19 vaccine design codenamed mRNA-1273

- In Feb 20, the WHO stated it does not expect a vaccine to be available for 18 months. WHO's minimum criterion for COVID-19 vaccine efficacy rate ‘~ 50% point estimate’

- In Mar 20, the WHO declared COVID-19 a pandemic

- In Nov 20 barely 9 months after WHO's forecast for a vaccine, Phase III clinical trial results of mRNA vaccines were released
- Efficacy rates - Pfizer-BioNtech 95%; Moderna 94.1% - far exceeding requirements and what was ever thought possible

- In Dec 20, both mRNA vaccines were approved. Mass vaccinations in many parts of the world began

- The mRNA vaccines (and others) took less than 1 year to develop from proof of concept to human trials to approvals – what it takes on average 10 years to achieve

- mRNA vaccines are ground breaking medical technology that has multiple uses outside of the pandemic

All unparalleled feats and a miracle of modern medicine


Total Doses in 2021 (as at 28 Dec 20)

- Pfizer-BioNTech: 1.3 billion doses
- Moderna: 500 million - 1 billion doses
- AstraZeneca: 3 - 4.5 billion doses
- Novavax (1.3bil); Curevac (~400mil); J&J (~1bil)
- Gamaleya Institute Sputnik V (~1.2 bil doses)
- China - Sinopharm (2; ~1bil); Sinovac; Cansino

Total: 9.7 - 11.7 billion doses


The COVID-19 pandemic is over

Mankind has won


Sincerely,
EMSVSI

Didn't tank the KLCI today not bad keep it up

Today didn't tank the KLCI not too bad keep it up

The glove lovers gave up and came over to numbawan top pick 2021 recovery sure win stock Genting is it ha ha ha

Ha ha ha you don't know how valuations work if you include the debts go learn accounting then come back and tell me why you need to include debts ha ha ha

Target Price (at 19 Jan 2021 @ 5.00pm)
--------------------------------

1st TP: RM 7.59 (Market Capitalisation of Listed Entity only)

Entity: Ownership (%) and Market Capitalisation and Exchange Rate = Value (RM Billion) at Share Price or Value per Genting share

GenS: 52.7% x SGD 10.497 bil x 3.04 = RM 16.816 bil (@ SGD0.87 or 87c) or RM4.34

GenM: 49.5% x MYR 14.311 bil = RM 7.084 bil (@ RM2.41) or RM1.83

GenP: 55.4% x MYR 8.749 bil = RM 4.847 bil (@ RM9.75) or RM1.25

Celularity: 10% x USD 1.7 bil 4.04 = RM0.687 bil (*2Q21 listing; assumes 10% only) or RM0.177

Number of Shares: 3.877 bil

Most conservative method taking into account the market capitalisation of GenS GenM GenP only, while assigning ZERO value to Energy, Life Sciences, Management Services etc

Even at the most conservative target price RM7.59, the upside potential from current share price RM4.23 is significant i.e. 79.5%

The value of GenS alone is RM4.34 per Genting share

And they definitely use gloves when playing on the tables...ha ha ha

Thats true people from Kedah Perak Negeri Sembilan Terengganu Pahang Perlis all go to Genting and play on the gaming tables ha ha ha

Shut up and start buying and stop tanking the KLCI la

Hang Seng Index is made up of Finance, Insurance, Utilities, Properties, Commerce (Logistics/Shipping/Ports) etc. All cyclical/value stocks ie recovery.

As mentioned the world over, recovery stocks are rising. Only in Bursa pandemic stocks are still in play

The first step is always the hardest but once the vaccinations have started bottlenecks are quickly resolved. Then science and medicine will do its work

Tide is turning

Post removed.Why?

Genting does not require international travellers, although it is nice

GenM Domestic/Locals make up 75-80% of EBITDA (proof 3Q20 vs 3Q19)
GenS Singapore has opened its borders - even though China has had an increase in cases, again with their current lockdown AND vaccines, they will overcome it quickly. Note, with nowhere to travel, RWS may see an increase in visitations
GenP and Power, Property, O&G are cyclical sectors in a massive upcycle
Life Sciences - Celularity Inc listing in 2Q21 - massive yet to be factored-in value to be unlocked - see similar genomics companies in the US

Post removed.Why?

Gloves give you dividends...but your capital loss...can cover boh ha ha ha (its a rhetorical question, we all know you guys are suffering every second of every day as vaccines are produced...)

My advice to glove lovers is keep buying and averaging down...then sell house sell property sell land sell family take on margin and keep buying...then pray there is a rebound for you to cut loss because if it doesnt come then margin call will come when glove share price reverts back to pre-covid levels as history has shown repeatedly after every pandemic...ho ho ho

You don't know valuations and finance better to keep quiet. Just keep following the glove herd...I remember seeing a drawing of the herd all moving together...until the end of the road...and then all together falling off the cliff...which is actually surprisingly gasps kinda like...the situation in gloves...with retailers right now ha ha ha

They can borrow RM9bil and give out dividends, LKT say you blow ah :)

And Genm's net debt to equity is only ~ 0.4 :)

At net debt:equity of 1, they can raise another RM9 bil just for the heck of it :)

Genm has been posting losses since many quarters ago. Share price has been climbing with some international gaming stocks even higher than precovid ho ho ho. Tesla has been forever loss making, only recently making a profit due to 'carbon credits'. And yet share price...ha ha ha

Topglove has been posting increasing profits and share price.....lol if stock market was so easy and every aunty uncle ali abu ahkow also take next year's supernormal profits times 10, everybody will be a trillionaire :)

All you need to ask is in 6, 12, 18 months time, what would the world be like, knowing that vaccines are already being rolled out with efficacy's that are above 90%. Ignore the glove lovers, they are panicking and peeing their pants because every day we get closer to normalcy, their investments are sinking ever deeper...ha ha ha

Post removed.Why?

Started the week at RM4.03...
Highest risk events MCO2.0 and State of Emergency came to pass...
Closed the week at RM4.30 ha ha ha
Genting's uptrend is intact and unstoppable

Sincerely,
EMSVSI

Israel Vaccine Data Suggests Decrease in Covid-19 Infection Rate After First Dose

The early data, indicating a 33% decline, could offer lessons to other countries rolling out vaccination campaigns

Israel says it’s on track to vaccinate everyone over 16 by the end of March

By Felicia Schwartz and Dov Lieber
Jan. 14, 2021 4:10 pm ET

TEL AVIV—Early data from Israel suggests Covid-19 infection rates began to decrease among a group of vaccine recipients two weeks after they received the first shot of Pfizer Inc. and BioNTech SE ’s vaccine, offering important insights to other countries as they roll out their own campaigns.

The small country—whose roughly nine million population is about the size of New York City’s—has vaccinated nearly a fourth of its population in just under a month, the first country to hit that mark as it fights an upsurge in new infections.

Israel’s largest health-care provider, Clalit Health Services, compared test positivity rates among 200,000 people over 60 who received the vaccine with 200,000 that didn’t. Until day 14, there was little difference between the two groups. But after that, the data showed a 33% fall in infection rates among those who had already been vaccinated compared with those who hadn’t.

https://www.wsj.com/articles/israel-vaccine-data-suggests-decrease-in-covid-19-infection-rate-after-first-dose-11610658607

Note: 1st shot already reduced infection rates


Anti-vaxxers/Glovers: But infection rates and deaths are still increasing !

Ans: The vaccines were just administered - your body needs to produce the neutralising antibodies. In Feb/Mar you will start to see a decline...and then infection rates will drop off the cliff - yes all the way to zero as everyone is inoculated and immunity is achieved. No gradual decline. Think about what that does to glove orders and ASPs